Contents of this document
- Established AnyAI Lab, an AI development center, in Hangzhou, China
- Applied development of autonomous AI agents
- Mass production of video content using AI
- Accelerating the rollout of AnyLive, an AI-powered streaming platform, in Japan
- Using Sun Smile's network to distribute existing supported brands to retail stores
- OMO marketing using store POS data
- Adjusted EBITDA¥1,540 millionYear on year against the same period last year+59.1%
- Monthly gross profit per employeeYear on year against the same period last year+34%
- Overseas Revenue Mix52 %
- Target market15 countries and regions
- Proportion of employees at overseas locations73 %
- Total social media followers of seju3,800 10,000 people
- Advanced Clinicals' domestic TikTok Shop GMV1 over ¥100 million first half of 2026
| Item | Details |
|---|---|
| Document type | Presentation materials for financial results |
| Fiscal Period Covered | Second quarter of the fiscal year ending December 2026 |
| Net Sales | ¥20,466 million (YoY +55.0%) |
| Operating profit | ¥861 million (YoY +93.1%) |
| Net income | ¥326 million (profit attributable to owners of the parent) (YoY +159.8%) |
| Gross Profit Margin | Rate 38.3% (Q2), 38.2% (first-half cumulative) / Year on year against the same period last year -0.7 percentage points (Q2), -0.5 percentage points (first-half cumulative) |
| Selling, general and administrative expenses | ¥6,916 million (Q2) |
| Results for the three months of the current quarter | Revenue ¥20,466 million, up 55.0% year on year / Gross profit ¥7,829 million, up 52.2% year on year / Operating profit ¥861 million, up 93.1% year on year / Profit for the period attributable to owners of the parent ¥326 million, up 159.8% year on year / Adjusted EBITDA ¥1,540 million, up 59.1% year on year |
| Full-year earnings forecast | Revenue ¥79,110 million / Gross profit ¥30,350 million / Operating profit ¥3,060 million / Profit for the period attributable to owners of the parent ¥1,630 million / Gross Profit Margin 38.4% / Operating profit margin 3.9% / Net profit margin 2.1% |
| Progress against full-year forecast | Revenue 48% / Gross profit 48% / Operating profit 34% / Profit for the period attributable to owners of the parent 30% |
| Self-assessment against the plan | Progressing steadily ahead of the forecast |
| Segment results | Marketing Revenue ¥7,701 million, up 23.9% year on year / Gross profit ¥3,020 million, up 20.4% year on year / D2C/EC Revenue ¥8,798 million, up 160.7% year on year / Gross profit ¥3,175 million, up 154.4% year on year / Publisher support Revenue ¥2,425 million, up 2.3% year on year / Gross profit ¥740 million, up 2.9% year on year / Creator support Revenue ¥1,489 million, up 27.7% year on year / Gross profit ¥852 million, up 42.9% year on year / Other Revenue ¥50 million, down 32.2% year on year / Gross profit ¥40 million, down 42.2% year on year |
| Breakdown of Factors Affecting the Change | Strong performance in existing businesses Organic gross profit growth of 35% year on year / Increase in SG&A expenses Up 32% year on year; headcount increased by 169 year on year / M&A contribution Earnings contribution from companies that joined the group in Q1 2026 / Decrease in other revenue Not disclosed |
| Key KPIs | Indicator name Adjusted EBITDA / Value ¥1,540 million / Year on year against the same period last year +59.1%, Indicator name Monthly gross profit per employee / Value Not disclosed / Year on year against the same period last year +34%, Indicator name Overseas Revenue Mix / Value 52 % / Year on year against the same period last year Not disclosed, Indicator name Target market / Value 15 countries and regions / Year on year against the same period last year Not disclosed, Indicator name Proportion of employees at overseas locations / Value 73 % / Year on year against the same period last year Not disclosed, Indicator name Total social media followers of seju / Value 3,800 10,000 people / Year on year against the same period last year Not disclosed, Indicator name Advanced Clinicals' domestic TikTok Shop GMV / Value 1 over ¥100 million (first half of 2026) / Year on year against the same period last year Not disclosed |
| Unit price and quantity metrics | The materials include the number of D2C/EC brands handled, revenue per brand, number of contracted publishers, revenue and gross profit per publisher, number of contracted creators, and revenue and gross profit per creator. Individual figures are shown in charts; exact figures are not disclosed. |
| Number of stores and locations | Established AnyAI Lab, an AI development center, in Hangzhou, China. The number of stores and the number of store openings and closures during the period are not disclosed. |
| Number of employees | Q2 headcount decreased slightly. The exact headcount and hiring plan are not disclosed. |
| Assumptions Underlying the Business Outlook | Corporate brand support revenue growth rate +57% / Marketing revenue growth rate +33% / D2C/EC revenue growth rate +93% / Publisher support revenue growth rate +2% / Creator support revenue growth rate ▲34% / Corporate brand support gross profit growth rate +59% / Marketing gross profit growth rate +27% / D2C/EC gross profit growth rate +116% / Publisher support gross profit growth rate 0% / Creator support gross profit growth rate ▲38% / Operating profit margin 3.9% / Non-operating foreign-exchange loss ¥200 million included in the forecast |
| Risk amount incorporated into the outlook | ¥200 million included as a buffer for foreign exchange fluctuations, recognized as a non-operating foreign exchange loss |
| Medium-term management plan targets | Progress toward achieving the 2027 medium-term targets. Specific target figures are not disclosed. |
| Financial targets | Equity ratio 37.4% at 31 December 2025, 34.2% at 30 June 2026 / Debt-to-equity ratio 0.57x at 31 December 2025, 0.72x at 30 June 2026 / Goodwill-to-net-assets ratio 0.23x at 31 December 2025, 0.47x at 30 June 2026 |
| Annual Dividend | Annual dividend per share is not disclosed. Year-end dividend forecast: ¥2.0. Interim dividend is not disclosed. |
| Acquisition of treasury shares | Total acquisition price ¥500 million (maximum) / Number of shares acquired 1,250,000 shares (maximum) / Acquisition period 18 May 2026–31 August 2026 / Actual results as of 31 July 2026 839,600 shares, ¥409,708,100 |
| New initiatives | Established AnyAI Lab, an AI development center, in Hangzhou, China, Applied development of autonomous AI agents, Mass production of video content using AI, Accelerating the rollout of AnyLive, an AI-powered streaming platform, in Japan, Using Sun Smile's network to distribute existing supported brands to retail stores, OMO marketing using store POS data |
Items this document does not state (7)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company cited growth in the corporate brand support business, the consolidated impact of 3 companies acquired in January 2026, strong performance in existing businesses, restrained growth in selling, general and administrative expenses, and increased earnings contributions from acquired companies as factors behind the increase in profit.